HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complement abnormalities during an epidemic of group B meningococcal infection in children.

Abstract
During an epidemic of group B meningococcal infection mean values obtained in 96 consecutively affected children showed a reduction in classical pathway function (CH50), normal alternate pathway function (AP50), C4 and factor B levels, and raised C3 levels. CH50, C3 and Factor B were however significantly lower in those children who had a rapid onset of illness, were in shock, had signs of septicaemia, had extensive skin purpura, or who died. The presence of detectable meningococcal antigen by Counter Immuno Electrophoresis (CIE) and laboratory evidence of Disseminated Intravascular Coagulation (DIC) also correlated with lower complement levels. The significant reduction in CH50 and Factor B in the more severely affected patients suggests that activation of both classical and alternate pathways occurs in group B meningococcal infection.
AuthorsD W Beatty, C R Ryder, H D Heese
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 64 Issue 3 Pg. 465-70 (Jun 1986) ISSN: 0009-9104 [Print] England
PMID3491693 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Complement C3
  • Complement C4
  • Complement System Proteins
  • Complement Factor B
Topics
  • Child
  • Child, Preschool
  • Complement C3 (analysis)
  • Complement C4 (analysis)
  • Complement Factor B (analysis)
  • Complement Pathway, Alternative
  • Complement Pathway, Classical
  • Complement System Proteins (analysis)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Meningococcal Infections (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: